As clinical trials demonstrated a protective effect of GLP-1 RAs on the cardiovascular safety in patients with T2DM [14,64] and GLP-1R was reported to be widely expressed in the cardiovascular system [65], several studies set out to investigate if genetic variability of GLP1R is associated with cardiovascular complications among patients with T2DM. Here, GLP1R is linked to type 2 diabetes mellitus.